Clinical trial
Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
NCT00323154 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00323154 |
|---|---|
| Title | Nalbuphine for the Treatment of Opioid Induced Pruritus in Children |
| Official title | Nalbuphine for the Treatment of Opioid Induced Pruritus in Children |
| Lead sponsor | University of British Columbia, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pruritis |
| Intervention type | Drug |
| Interventions | Nalbuphine |
| Enrollment | 134 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | May 9, 2006 |
| Last update posted | Sep 25, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: